304 related articles for article (PubMed ID: 8900407)
1. Association of proteoglycan degradation with catabolic cytokine and stromelysin release from cartilage cultured with fibronectin fragments.
Homandberg GA; Hui F
Arch Biochem Biophys; 1996 Oct; 334(2):325-31. PubMed ID: 8900407
[TBL] [Abstract][Full Text] [Related]
2. Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases: stromelysin plays a major role in chondrolysis.
Xie DL; Hui F; Meyers R; Homandberg GA
Arch Biochem Biophys; 1994 Jun; 311(2):205-12. PubMed ID: 8203882
[TBL] [Abstract][Full Text] [Related]
3. High concentrations of fibronectin fragments cause short-term catabolic effects in cartilage tissue while lower concentrations cause continuous anabolic effects.
Homandberg GA; Hui F
Arch Biochem Biophys; 1994 Jun; 311(2):213-8. PubMed ID: 8203883
[TBL] [Abstract][Full Text] [Related]
4. Exposure of cartilage to a fibronectin fragment amplifies catabolic processes while also enhancing anabolic processes to limit damage.
Homandberg GA; Wen C
J Orthop Res; 1998 Mar; 16(2):237-46. PubMed ID: 9621898
[TBL] [Abstract][Full Text] [Related]
5. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
Yasuda T; Poole AR
Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586
[TBL] [Abstract][Full Text] [Related]
6. Proteoglycan degradation after injurious compression of bovine and human articular cartilage in vitro: interaction with exogenous cytokines.
Patwari P; Cook MN; DiMicco MA; Blake SM; James IE; Kumar S; Cole AA; Lark MW; Grodzinsky AJ
Arthritis Rheum; 2003 May; 48(5):1292-301. PubMed ID: 12746902
[TBL] [Abstract][Full Text] [Related]
7. Fibronectin-fragment-induced cartilage chondrolysis is associated with release of catabolic cytokines.
Homandberg GA; Hui F; Wen C; Purple C; Bewsey K; Koepp H; Huch K; Harris A
Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):751-7. PubMed ID: 9032463
[TBL] [Abstract][Full Text] [Related]
8. Fibronectin fragment mediated cartilage chondrolysis. I. Suppression by anti-oxidants.
Homandberg GA; Hui F; Wen C
Biochim Biophys Acta; 1996 Nov; 1317(2):134-42. PubMed ID: 8950199
[TBL] [Abstract][Full Text] [Related]
9. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan enhances cartilage repair through low grade tissue remodeling involving cytokines and matrix metalloproteinases.
Homandberg GA; Ummadi V; Kang H
Inflamm Res; 2004 Oct; 53(10):534-43. PubMed ID: 15597148
[TBL] [Abstract][Full Text] [Related]
12. Production of cytokines by chondrocytes and its role in proteoglycan degradation.
Shinmei M; Masuda K; Kikuchi T; Shimomura Y; Okada Y
J Rheumatol Suppl; 1991 Feb; 27():89-91. PubMed ID: 2027138
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis: I. In vitro.
Homandberg GA; Hui F; Wen C; Kuettner KE; Williams JM
Osteoarthritis Cartilage; 1997 Sep; 5(5):309-19. PubMed ID: 9497938
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan suppresses fibronectin fragment-mediated damage to human cartilage explant cultures by enhancing proteoglycan synthesis.
Kang Y; Eger W; Koepp H; Williams JM; Kuettner KE; Homandberg GA
J Orthop Res; 1999 Nov; 17(6):858-69. PubMed ID: 10632453
[TBL] [Abstract][Full Text] [Related]
15. Mechanical injury potentiates proteoglycan catabolism induced by interleukin-6 with soluble interleukin-6 receptor and tumor necrosis factor alpha in immature bovine and adult human articular cartilage.
Sui Y; Lee JH; DiMicco MA; Vanderploeg EJ; Blake SM; Hung HH; Plaas AH; James IE; Song XY; Lark MW; Grodzinsky AJ
Arthritis Rheum; 2009 Oct; 60(10):2985-96. PubMed ID: 19790045
[TBL] [Abstract][Full Text] [Related]
16. Telopeptides of type II collagen upregulate proteinases and damage cartilage but are less effective than highly active fibronectin fragments.
Guo D; Ding L; Homandberg GA
Inflamm Res; 2009 Mar; 58(3):161-9. PubMed ID: 19190855
[TBL] [Abstract][Full Text] [Related]
17. The role of cytokines in osteoarthritis pathophysiology.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
[TBL] [Abstract][Full Text] [Related]
18. Intraarticular injection of fibronectin fragments causes severe depletion of cartilage proteoglycans in vivo.
Homandberg GA; Meyers R; Williams JM
J Rheumatol; 1993 Aug; 20(8):1378-82. PubMed ID: 8230023
[TBL] [Abstract][Full Text] [Related]
19. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
Kobayashi M; Squires GR; Mousa A; Tanzer M; Zukor DJ; Antoniou J; Feige U; Poole AR
Arthritis Rheum; 2005 Jan; 52(1):128-35. PubMed ID: 15641080
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and mechanism of action of KHBJ-9B, a new herbal medicine, and its major compound triterpenoids in human cartilage culture and in a rabbit model of collagenase-induced osteoarthritis.
Huh JE; Baek YH; Ryu SR; Lee JD; Choi DY; Park DS
Int Immunopharmacol; 2009 Feb; 9(2):230-40. PubMed ID: 19100343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
